【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Avonex/Rebif
04.1.2 Plegridy
04.1.3 Tecfidera
04.1.4 Tysabri
04.1.5 Comtan
04.1.6 Stalevo
04.1.7 Exelon/Exelon Patch
04.1.8 Extavia
04.1.9 Gilenya
04.1.10 Cerebyx
04.1.11 Dilantin-125
04.1.12 Lyrica
04.1.13 Neurontin
04.1.14 Zarontin
04.1.15 Azilect
04.1.16 Copaxone
04.1.17 Keppra/Keppra XR
04.1.18 Neupro
04.1.19 Vimpat
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08.Segmentation of Global Neurodegenerative Diseases Market by Type of Disease
09.Global Multiple Sclerosis Market
09.1 Multiple Sclerosis: Overview
09.1.1 About the Disease
09.1.2 Symptoms
09.1.3 Etiology
09.1.4 Epidemiology
09.1.5 Economic Burden
09.2 Market Overview
09.3 Market Size and Forecast
09.4 Multiple Sclerosis Market in US
09.4.1 Market Size and Forecast
10.Global Alzheimer’s Disease Market
10.1 Alzheimer’s Disease: Overview
10.1.1 About the Disease
10.1.2 Dementia
10.1.3 Epidemiology and Forecast
10.1.4 Types of Dementia
10.1.5 Global Burden
10.1.6 Etiology
10.1.7 Cost of Care
10.1.8 Alzheimer’s Disease and Caregiving
10.2 Market Overview
10.3 Market Size and Forecast
11.Global Epilepsy Market
11.1 Epilepsy: Overview
11.1.1 About the Disease
11.1.2 Etiology
11.1.3 Types of Epilepsy
11.1.4 Symptoms
11.1.5 Epidemiology
11.1.6 Economic Burden
11.2 Market Overview
11.3 Market Size and Forecast
11.4 Epilepsy Market in US
11.4.1 Market Size and Forecast
11.5 Epilepsy Market in Europe
11.5.1 Market Size and Forecast
11.6 Epilepsy Market in Japan
11.6.1 Market Size and Forecast
12.Global Parkinson’s Disease Market
12.1 Parkinson’s Disease: Overview
12.1.1 About the Disease
12.1.2 Symptoms
12.1.3 Etiology
12.1.4 Epidemiology
12.1.5 Economic Burden
12.2 Market Overview
12.3 Market Size and Forecast
13.Global Huntington’s Disease Market
13.1 Huntington’s Disease: Overview
13.1.1 About the Disease
13.1.2 Symptoms
13.1.3 Etiology
13.1.4 Prevalence of Huntington’s Disease
13.1.5 Pipeline Portfolio
13.1.6 Economic Burden
13.2 Market Overview
13.3 Market Size and Forecast
14.Global Amyotrophic Lateral Sclerosis Market
14.1 Amyotrophic Lateral Sclerosis: Overview
14.1.1 About the Disease
14.1.2 Types of Amyotrophic Lateral Sclerosis
14.1.3 Etiology and Pathophysiology
14.1.4 Symptoms
14.1.5 Epidemiology
14.1.6 Diagnosis
14.1.7 Pipeline Portfolio
14.2 Market Overview
14.3 Market Size and Forecast
15.Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule
15.1 Biologics
15.2 Small Molecules
16.Segmentation of Global Neurodegenerative Diseases Market by Route of Administration
16.1 Oral
16.2 Parenteral
16.3 Topical
17.Geographical Segmentation
18.Buying Criteria
19.Market Growth Drivers
20.Drivers and their Impact
21.Market Challenges
22.Impact of Drivers and Challenges
23.Market Trends
24.Trends and their Impact
25.Vendor Landscape
25.1 Competitive Scenario
25.1.1 Key News
25.1.2 Mergers and Acquisitions
25.2 Market Share Analysis 2014
25.2.1 Competitive Assessment of Major Drugs
25.2.2 Biogen Idec
25.2.3 Pfizer
25.2.4 Teva Pharmaceutical
25.2.5 Novartis
25.2.6 Merck Serono
25.2.7 UCB
25.3 Other and Potential Future Prominent Vendors
26.Key Vendor Analysis
26.1 Biogen Idec
26.1.1 Key Facts
26.1.2 Business Overview
26.1.3 Business Segmentation by Revenue 2013
26.1.4 Geographical Segmentation by Revenue 2013
26.1.5 Business Strategy
26.1.6 Key Developments
26.1.7 SWOT Analysis
26.2 Merck Serono
26.2.1 Key Facts
26.2.2 Business Overview
26.2.3 Geographical Segmentation by Revenue 2013
26.2.4 Business Strategy
26.2.5 Recent Developments
26.2.6 SWOT Analysis
26.3 Novartis
26.3.1 Key Facts
26.3.2 Business Description
26.3.3 Business Segmentation
26.3.4 Revenue by Business Segmentation
26.3.5 Revenue Comparison 2012 and 2013
26.3.6 Sales by Geography
26.3.7 Business Strategy
26.3.8 Key Developments
26.3.9 SWOT Analysis
26.4 Pfizer
26.4.1 Key Facts
26.4.2 Business Overview
26.4.3 Business Segmentation by Revenue 2013
26.4.4 Business Segmentation by Revenue 2012 and 2013
26.4.5 Geographical Segmentation by Revenue
26.4.6 Business Strategy
26.4.7 Key Developments
26.4.8 SWOT Analysis
26.5 Teva Pharmaceutical
26.5.1 Key Facts
26.5.2 Business Overview
26.5.3 Business Segmentation
26.5.4 Business Segmentation by Revenue 2013
26.5.5 Business Segmentation by Revenue 2012 and 2013
26.5.6 Sales by Geography
26.5.7 Business Strategy
26.5.8 Key Developments
26.5.9 SWOT Analysis
26.6 UCB
26.6.1 Key Facts
26.6.2 Business Overview
26.6.3 Product Segmentation by Revenue 2013
26.6.4 Product Segmentation by Revenue 2012 and 2013
26.6.5 Geographical Segmentation by Revenue 2013
26.6.6 Business Strategy
26.6.7 Recent Developments
26.6.8 SWOT Analysis
27.Other Reports in this Series
List Of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Neurodegenerative Diseases Market 2014-2019 ($ million)
Exhibit 3: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease
Exhibit 4: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease 2014
Exhibit 5: Segmentation of Global Neurodegenerative Diseases Market by Type of Disease 2019
Exhibit 6: Etiology of Multiple Sclerosis
Exhibit 7: Global Multiple Sclerosis Market 2014-2019 ($ million)
Exhibit 8: Multiple Sclerosis Market in US 2014-2019 ($ million)
Exhibit 9: Prevalence of Dementia by Geography 2013, 2030, and 2050 (million)
Exhibit 10: Prevalence of Dementia by Geography 2013-2018 (millions)
Exhibit 11: Types of Dementia and Associated Symptoms
Exhibit 12: Types of Dementia by Prevalence 2013
Exhibit 13: Segmentation of Economic Burden of Alzheimer’s Disease and Other Dementias by Geography 2013
Exhibit 14: Average Cost of Care for Americans Aged 65 and Above with Alzheimer’s Disease and Other Dementias 2013
Exhibit 15: Distribution of Alzheimer’s Caregivers by Age 2013
Exhibit 16: Projected Prevalence of Dependence 2010 and 2030
Exhibit 17: Global Alzheimer’s Disease Market 2014-2019 ($ million)
Exhibit 18: Global Epilepsy Market 2014-2019 ($ million)
Exhibit 19: Epilepsy Market in US 2014-2019 ($ million)
Exhibit 20: Epilepsy Market in Europe 2014-2019 ($ million)
Exhibit 21: Epilepsy Market in Japan 2014-2019 ($ million)
Exhibit 22: Global Parkinson’s Disease Market 2014-2019 ($ million)
Exhibit 23: Segmentation of Global Parkinson’s Disease Market by Country 2014
Exhibit 24: Snapshot of Disease
Exhibit 25: Prevalence of Huntington’s Disease by Geography 2013
Exhibit 26: Huntington’s Disease: Pipeline Portfolio
Exhibit 27: Global Huntington’s Disease Market 2014-2019 ($ million)
Exhibit 28: Snapshot of Disease
Exhibit 29: Amyotrophic Lateral Sclerosis: Pipeline Portfolio
Exhibit 30: Global Amyotrophic Lateral Sclerosis Market 2014-2019 ($ million)
Exhibit 31: Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule
Exhibit 32: Segmentation of Global Neurodegenerative Diseases Market by Type of Molecule 2014
Exhibit 33: Segmentation of Global Neurodegenerative Diseases Market by Route of Administration
Exhibit 34: Segmentation of Global Neurodegenerative Diseases Market by Route of Administration 2014
Exhibit 35: Segmentation of Global Neurodegenerative Diseases Market by Geography 2014
Exhibit 36: Global Neurodegenerative Diseases Market Share Analysis 2014
Exhibit 37: Major Drugs for Neurodegenerative Diseases by Revenue 2014 ($ million)
Exhibit 38: YoY Revenue of Major Drugs for Neurodegenerative Diseases 2011-2014 ($ million)
Exhibit 39: Revenue Share of Major Drugs for Neurodegenerative Diseases 2011-2014
Exhibit 40: Biogen Idec: Global Revenue of Products 2011-2014 ($ million)
Exhibit 41: Biogen Idec: YoY Global Revenue of Avonex 2011-2014 ($ million)
Exhibit 42: Biogen Idec: Revenue of Avonex in US 2011-2014 ($ million)
Exhibit 43: Biogen Idec: Revenue of Avonex in ROW 2011-2014 ($ million)
Exhibit 44: Biogen Idec: YoY Global Revenue of Tysabri 2011-2014 ($ million)
Exhibit 45: Biogen Idec: Revenue of Tysabri in US 2011-2014 ($ million)
Exhibit 46: Biogen Idec: Revenue of Tysabri in ROW 2011-2014 ($ million)
Exhibit 47: Biogen Idec: YoY Global Revenue of Fampyra 2011-2014 ($ million)
Exhibit 48: Biogen Idec: Revenue of Plegridy in US and ROW 2014 ($ million)
Exhibit 49: Biogen Idec: Revenue of Tecfidera in US and ROW 2013 and 2014 ($ million)
Exhibit 50: Pfizer: YoY Global Revenue of Lyrica 2011-2014 ($ million)
Exhibit 51: Pfizer: YoY Global Revenue of Neurontin 2011-2013 ($ million)
Exhibit 52: Teva Pharmaceutical: YoY Global Revenue of Copaxone 2011-2014 ($ million)
Exhibit 53: Teva Pharmaceutical: Quarterly Revenue of Copaxone 2011-2014 ($ million)
Exhibit 54: Teva Pharmaceutical: YoY Global Revenue of Azilect 2011-2014 ($ million)
Exhibit 55: Teva Pharmaceutical: Quarterly Revenue of Azilect 2011-2014 ($ million)
Exhibit 56: Novartis: YoY Global Revenue of Gilenya 2011-2014 ($ million)
Exhibit 57: Novartis: Revenue of Gilenya in US and ROW 2011-2013 ($ million)
Exhibit 58: Novartis: YoY Global Revenue of Extavia 2011-2014 ($ million)
Exhibit 59: Novartis: YoY Global Revenue of Comtan/Stalevo 2011-2014 ($ million)
Exhibit 60: Novartis: Revenue of Comtan/Stalevo in US and ROW 2011-2013 ($ million)
Exhibit 61: Novartis: YoY Global Revenue of Exelon/Exelon Patch 2011-2014 ($ million)
Exhibit 62: Novartis: Revenue of Exelon/Exelon Patch in US and ROW 2011-2013 ($ million)
Exhibit 63: Merck Serono: YoY Global Revenue of Rebif 2011-2014 ($ million)
Exhibit 64: Merck Serono: Revenue of Rebif in North America 2011-2014 ($ million)
Exhibit 65: Merck Serono: Revenue of Rebif in Europe 2011-2014 ($ million)
Exhibit 66: Merck Serono: Revenue Share of Rebif by Region 2012-2014
Exhibit 67: UCB: YoY Global Revenue of Vimpat 2011-2014 ($ million)
Exhibit 68: UCB: YoY Revenue of Vimpat in Europe 2011-2014 ($ million)
Exhibit 69: UCB: YoY Revenue of Vimpat in North America 2011-2014 ($ million)
Exhibit 70: UCB: YoY Global Revenue of Keppra/Keppra XR 2011-2014 ($ million)
Exhibit 71: UCB: YoY Revenue of Keppra/Keppra XR in Europe 2011-2014 ($ million)
Exhibit 72: UCB: YoY Revenue of Keppra/Keppra XR in North America 2011-2014 ($ million)
Exhibit 73: UCB: YoY Global Revenue of Neupro 2011-2014 ($ million)
Exhibit 74: UCB: YoY Revenue of Neupro in Europe 2011-2014 ($ million)
Exhibit 75: UCB: YoY Revenue of Neupro in North America 2011-2014 ($ million)
Exhibit 76: Biogen Idec: Business Segmentation by Revenue 2013
Exhibit 77: Biogen Idec: Geographical Segmentation by Revenue 2013
Exhibit 78: Merck Serono: Geographical Segmentation by Revenue 2013
Exhibit 79: Novartis AG: Business Segmentation
Exhibit 80: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 81: Novartis AG: Revenue by Business Segmentation 2012 and 2013 ($ million)
Exhibit 82: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 83: Pfizer: Business Segmentation by Revenue 2013
Exhibit 84: Pfizer: Business Segmentation by Revenue 2012 and 2013
Exhibit 85: Pfizer: Geographical Segmentation by Revenue 2013
Exhibit 86: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 87: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 88: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 89: Teva Pharmaceutical Industries: Sales by Geography 2013
Exhibit 90: UCB: Product Segmentation by Revenue 2013
Exhibit 91: UCB: Product Segmentation by Revenue 2012 and 2013 ($ million)
Exhibit 92: UCB: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：神経変性疾患治療薬の世界市場：アルツハイマー型認知症、パーキンソン病、多発性硬化症、てんかん、ハンチントン病、筋萎縮性側索硬化症■ 英文：Global Neurodegenerative Diseases Market 2015-2019
■ 発行日：2015年5月6日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5793
■ 調査対象地域：グローバル
- とうもろこし粉の世界市場2017-2021ABSTRACTAbout Corn Flour The growing demand for Latin foods and the growing population of Hispanics are the prime factors driving the demand for corn four. In addition, the growth in the baking industry and food service segments and the growing popularity of corn-based snack products are the other drivers for the market growth. Established vendors are forming partnerships and strategic alliances, …
- 世界の40/100Gイーサネットネットワーク-MPOコネクター市場2015The Global 40/100G Ethernet Networks - MPO Connector Industry 2015 Market Research Report is a professional and in-depth study on the current state of the 40/100G Ethernet Networks - MPO Connector industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The 40/100G Ethernet Networks - MPO Connector market analy …
- 世界の産業自動化サービス市場動向（2014-2018）TechNavio's analysts forecast the Global Industrial Automation Services market to grow at a CAGR of 10.06 percent over the period 2013-2018. One of the key factors contributing to this market growth is the need to optimize the overall operational cost for end-users. The Global Industrial Automation Services market has also been witnessing the increasing demand of automation services from the APAC …
- アクリル酸の世界市場予測Acrylic acid 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about acrylic acid market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part …
- 世界の血液スクリーニング市場：技術別（核酸増幅、（リアルタイムPCR）、ELISA（化学発光免疫測定法）、ラピッドテスト、ウエスタンブロット）、製品別（機器、試薬＆キット、ソフトウェア）、エンドユーザー別（血液銀行、病院）“Increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are driving the overall growth of the blood screening market” The blood screening market is projected to reach USD 3.3 billion by 2024 from USD 2.2 billion in 2019, at a CAGR of 8.7%. Growth in this market is driven by the incre …
- 高圧ケーブルの世界市場：架空ケーブル、地中ケーブル、海底ケーブルThe global high voltage cables & accessories market is projected to grow at a CAGR of 6.0% during the forecast period, to reach USD 41.27 Billion by 2021. Offshore windfarms, high voltage direct current links, and grid interconnections are the major drivers of the high voltage cables & accessories market. Increasing need for grid interconnections is resulting in rising investments in the new subma …
- 世界の医療用電極市場：Global Medical Electrodes Market 2014-2018TechNavio forecasts The Global Medical Electrodes Market 2014-2018 with a CAGR of 12.20 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors t …
- 世界の熱伝導材料市場2015The Global Thermal Interface Material Industry Report 2015 is a professional and in-depth study on the current state of the Thermal Interface Material industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Thermal Interface Material market analysis is provided for the international markets including devel …
- 世界の産業用ワイヤレスセンサーネットワーク（IWSN）市場動向（2012-2016）TechNavio's analysts forecast the Global Industrial Wireless Sensor Networks (IWSN) market to grow at a CAGR of 14.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the cost benefit offered by wireless sensors when compared with traditional wired sensors. Furthermore, certain trends in the development of wireless technologies are providing wireless s …
- 顔認証の世界市場予測（～2024年）The global facial recognition market size to grow at a Compound Annual Growth Rate (CAGR) of 16.6% during the forecast periodMarketsandMarkets forecasts the global facial recognition market size to grow from USD 3.2 billion in 2019 to USD 7.0 billion by 2024, at a CAGR of 16.6% during 2019–2024. The rising need for surveillance has become one of the major factors to drive the facial recognition ma …
- 洗顔ペーパーの世界市場2016-2020Facial wipes can be categorized under skincare products. A wide range of facial wipes that have plant-derived solutions and synthetic water and oil-based solutions is sold under two broad categories: wet facial wipes and dry facial wipes. Based on the effects, facial wipes can be of the following types: anti-inflammatory, rejuvenation and regeneration, moisturizing, nourishing, firming and smoothi …
- 天然油ポリオール（NOP）の世界市場分析、製品別（大豆油、ヒマシ油、パーム油、キャノーラ油、ヒマワリ油）、セグメント予測The global natural oil polyols (NOP) market is expected to reach USD 11.30 billion by 2024, according to a new report by Grand View Research, Inc. Growing demand for environment-friendly polymers on account of volatile prices of conventional plastics/polymers is expected to drive global NOP market. Regulatory support in the form of financial incentives from European Commission for the adoption of …
- 種子の世界市場：穀物種子、油料種子、果物種子、野菜種子、除草剤耐性種子、昆虫耐性種子The global seeds market has been projected to reach a value of $92.04 billion by 2020, driven primarily by the increasing demand for food in tandem with the growing global population, declining arable land, technology driven agricultural farming, and extensive use of biotechnology in seed development. Intensive research and development efforts by seed companies have brought about evolved strains o …
- 旅行保険の世界市場2016-2020About the Travel Insurance Market Travel insurance covers the expense, such as trip cancellation, cancellation due to the medical emergency, resulting from unexpected events during domestic and international travel. Some of these policies also pay for damage to rented equipment, such as car, or for ransom in case of kidnapping. Many online companies that sell flight tickets or tour packages offer …
- 尿素の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world urea market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight into …
